Unknown

Dataset Information

Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencing.


ABSTRACT: Many biology-based precision drugs are available that neutralize aberrant molecular pathways in cancer. Molecular heterogeneity and the lack of reliable companion diagnostic biomarkers for many drugs makes targeted treatment of cancer inaccurate for many individuals. Identifying actionable hyperactive biological pathways in individual cancers may improve this situation.To achieve this we applied a novel targeted RNA next generation sequencing (t/RNA-NGS) technique to surgically obtained glioma tissues. The test combines mutation detection with analysis of biological pathway activities that are involved in tumour behavior in many cancer types (e.g. tyrosine kinase signaling, angiogenesis signaling, immune response, metabolism), via quantitative measurement of transcript levels and splice va

SUBMITTER: Lenting K 

PROVIDER: S-EPMC6865071 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature